BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2135 related articles for article (PubMed ID: 9177382)

  • 1. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
    Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing's syndrome: a comparison with other tests.
    Shi X; Sun Q; Bian L; Zhao W; Shen J; Wang W; Ning G
    Neuro Endocrinol Lett; 2011; 32(6):865-73. PubMed ID: 22286783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
    Blunt SB; Sandler LM; Burrin JM; Joplin GF
    Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
    Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
    Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome.
    Castinetti F; Morange I; Dufour H; Jaquet P; Conte-Devolx B; Girard N; Brue T
    Eur J Endocrinol; 2007 Sep; 157(3):271-7. PubMed ID: 17766708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 107.